LipiCell

LipiCell is an investigational regenerative medicine product being developed as a cell-based therapy intended to reduce inflammation and promote tissue repair in damaged or diseased tissues, potentially as a complement to Bioheart’s/Myocell’s cardiac muscle-regeneration approach.[7] Public information on LipiCell is extremely limited, but available descriptions group it with MyoCell as part of a portfolio of cell-based regenerative products aimed at modulating inflammation and enhancing healing in scarred or chronically injured tissue.[7] Its precise cell source, target indications, dosing regimen, and detailed mechanism of action have not been disclosed in accessible regulatory or clinical trial documents, and it does not appear to be approved for any indication.